To The Moon

ImmunityBio, Inc. announced preliminary select operational results for the fiscal quarter and full year ending December 31, 2025. The company reported preliminary net product revenue of approximately $38.3 million for the fourth quarter of 2025, representing a 20% increase over the $31.8 million recorded in the third quarter of 2025 and a 431% increase compared to the same period in 2024. For the full year, preliminary net product revenue reached $113 million, reflecting a 700% year-over-year increase. ImmunityBio also reported a 54% quarter-over-quarter unit volume growth rate during fiscal year 2025. As of December 31, 2025, the company had an estimated $242.8 million in cash, cash equivalents, and marketable securities. The company attributed this growth to increased adoption of ANKTIVA and highlighted recent regulatory approvals in Saudi Arabia, the U.S., the U.K., and conditional approval in the EU.

Energy Fuels Inc. has announced a major expansion of its rare earth element processing capabilities at its White Mesa Mill in Utah, backed by a new Bankable Feasibility Study. The company plans to invest $410 million in a Phase 2 circuit expansion that will enable annual production of 6,000 tonnes of neodymium-praseodymium , 240 tonnes of dysprosium, and 66 tonnes of terbium. With this expansion, Energy Fuels aims to supply 45% of total U.S. rare earth demand in the near term, including 100% of domestic requirements for critical heavy rare earths by 2030. The project is expected to generate approximately $765 million in annual EBITDA over the first 15 years, positioning Energy Fuels as a leading, low-cost rare earth producer outside of China.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be